Abbott Labs Beats Second-Quarter Views, But Covid Testing Demand Dives

Abbott Laboratories (ABT) on Thursday reported adjusted earnings of $1.17 per share on $10.2 billion in sales for its second quarter. But ABT stock dipped a fraction.


On average, analysts polled by FactSet expected Abbott to earn $1.02 per share on $9.69 billion in sales.

In the year-earlier period, Abbott earnings were 57 cents a share on $7.33 billion in sales.

For the year, Abbott predicts adjusted profit of $4.30-$4.50 per share. Analysts called for adjusted profit of $4.36 per share and $39.39 billion in sales.

In premarket trading on the stock market today, ABT stock fell 0.2% near 118.80.

More to follow.

Follow Allison Gatlin on Twitter at @IBD_AGatlin.


Johnson & Johnson Shrugs Off Vaccine Worries But Stays Flat Despite Quarterly Beat

Intuitive Surgical Stock Nears $1,000 As The Covid Recovery Continues

IBD’s Leaderboard Is Celebrating 10 Years!

Options Trading: How To Start Using Options, How To Manage Risk

IBD Stock Of The Day: See How To Find, Track And Buy The Best Stocks

Most Related Links :
editorpen Governmental News Finance News

Source link

Back to top button